<DOC>
	<DOCNO>NCT01224483</DOCNO>
	<brief_summary>Paroxysmal nocturnal hemoglobinuria ( PNH ) hematopoietic stem cell disorder unregulated activation complement system lead significant ischemic morbidity shorten lifespan . Life-threatening thromboembolism ( TE ) fear complication PNH , account 45 % patient death . It estimate 40 % PNH patient experience clinically evident TE 60 % patient without clinically diagnose TE demonstrate TE high-sensitivity MRI , indicate ongoing thrombotic risk patient PNH . Much data come PNH patient European descent . To understand impact TE patient PNH non-European region , perform study evaluate clinical characteristic Korean patient PNH .</brief_summary>
	<brief_title>Multicenter Retrospective Analysis About Clinical Characteristics Korean Paroxysmal Nocturnal Hemoglobinuria ( PNH ) Patients</brief_title>
	<detailed_description>To evaluate clinical characteristic Korean PNH patient</detailed_description>
	<mesh_term>Hemoglobinuria , Paroxysmal</mesh_term>
	<mesh_term>Hemoglobinuria</mesh_term>
	<criteria>Diagnosis confirm Ham 's test Flow cytometry Patients Flow cytometry data Patients Flow cytometry data</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>